Skip to main content

ADVERTISEMENT

Jia Ruan, MD, PhD

Expert Roundtable
Videos
11/03/2023
In the first part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD, on the diagnostics and risk stratification of mantle cell lymphoma.
In the first part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD, on the diagnostics and risk stratification of mantle cell lymphoma.
In the first part of an expert...
11/03/2023
Oncology
KOL Roundtable
Videos
11/13/2023
Kami Maddocks, MD, discusses the role of non-covalent BTK inhibitors in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.
Kami Maddocks, MD, discusses the role of non-covalent BTK inhibitors in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.
Kami Maddocks, MD, discusses the...
11/13/2023
Oncology
KOL Roundtab
Videos
11/13/2023
In this expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on the best options for treating patients with relapsed/refractory mantle cell lymphoma.
In this expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on the best options for treating patients with relapsed/refractory mantle cell lymphoma.
In this expert roundtable...
11/13/2023
Oncology
KOL Roundtable
Videos
11/09/2023
In the second part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on goals and choice of frontline therapy for patients with mantle cell lymphoma.
In the second part of an expert roundtable series, Kami Maddocks, MD, leads a discussion with Jia Ruan, MD, PhD, and Krish Patel, MD on goals and choice of frontline therapy for patients with mantle cell lymphoma.
In the second part of an expert...
11/09/2023
Oncology
Jia Ruan, MD, PhD
Videos
11/15/2023
Jia Ruan, MD, PhD, discusses important factors to consider in determining mantle cell lymphoma prognosis, including the utilization of measurement tools like MIPI and genetic mutation profile data.
Jia Ruan, MD, PhD, discusses important factors to consider in determining mantle cell lymphoma prognosis, including the utilization of measurement tools like MIPI and genetic mutation profile data.
Jia Ruan, MD, PhD, discusses...
11/15/2023
Oncology
Jia Ruan, MD, PhD
Videos
11/03/2023
Jia Ruan, MD, PhD, shares 9-year follow-up findings from a phase 2 trial on the outcomes of chemotherapy-free lenalidomide plus rituximab combination therapy among patients with mantle cell lymphoma.
Jia Ruan, MD, PhD, shares 9-year follow-up findings from a phase 2 trial on the outcomes of chemotherapy-free lenalidomide plus rituximab combination therapy among patients with mantle cell lymphoma.
Jia Ruan, MD, PhD, shares 9-year...
11/03/2023
Oncology
KOL Roundtable
Videos
11/13/2023
Kami Maddocks, MD, reviews new possibilities and the latest advances in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.
Kami Maddocks, MD, reviews new possibilities and the latest advances in the treatment of patients with mantle cell lymphoma with Jia Ruan, MD, PhD, and Krish Patel, MD.
Kami Maddocks, MD, reviews new...
11/13/2023
Oncology